Integrated Cannabis Company Inc
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese… Read more
Integrated Cannabis Company Inc (CRPGF) - Total Liabilities
Latest total liabilities as of April 2025: $174.81 Billion USD
Based on the latest financial reports, Integrated Cannabis Company Inc (CRPGF) has total liabilities worth $174.81 Billion USD as of April 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Integrated Cannabis Company Inc - Total Liabilities Trend (2014–2024)
This chart illustrates how Integrated Cannabis Company Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Integrated Cannabis Company Inc Competitors by Total Liabilities
The table below lists competitors of Integrated Cannabis Company Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Beijing Hotgen Biotech Co Ltd
SHG:688068
|
China | CN¥278.25 Million |
|
Grenergy Renovables S.A
MC:GRE
|
Spain | €1.75 Billion |
|
Hainan Development Holdings Nanhai Co Ltd
SHE:002163
|
China | CN¥5.56 Billion |
|
Eyebright Medical Technology Beijing Co Ltd
SHG:688050
|
China | CN¥894.96 Million |
|
Koh Young Technology Inc
KQ:098460
|
Korea | ₩62.23 Billion |
|
Perpetual Ltd
AU:PPT
|
Australia | AU$1.77 Billion |
Liability Composition Analysis (2014–2024)
This chart breaks down Integrated Cannabis Company Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Integrated Cannabis Company Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Integrated Cannabis Company Inc (2014–2024)
The table below shows the annual total liabilities of Integrated Cannabis Company Inc from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-07-31 | $159.67 Billion | +3.82% |
| 2023-07-31 | $153.80 Billion | +13.94% |
| 2022-07-31 | $134.98 Billion | +7.50% |
| 2021-07-31 | $125.57 Billion | +15.19% |
| 2020-07-31 | $109.00 Billion | +12002612.55% |
| 2017-07-31 | $908.16K | +8.68% |
| 2016-07-31 | $835.61K | +4.50% |
| 2015-07-31 | $799.62K | +3.46% |
| 2014-07-31 | $772.90K | -- |